We are live on ! Find out more
MCM

Maryland Capital Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 18.21%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
-18.21%
3 Year Est. Return
+44.51%
5 Year Est. Return
+97.8%
10 Year Est. Return
AUM
$843M
AUM Growth
+$36M
Cap. Flow
+$3.64M
Cap. Flow %
0.43%
Top 10 Hldgs %
35.94%
Holding
190
New
11
Increased
81
Reduced
56
Closed
7

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$11.9M
2
ORLY icon
O'Reilly Automotive
ORLY
+$11.3M
3
DOW icon
Dow Inc
DOW
+$4.02M
4
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$2.1M
5
BA icon
Boeing
BA
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 17.59%
2 Healthcare 17.41%
3 Financials 14.2%
4 Consumer Discretionary 13.95%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
151
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$281K 0.03%
+3,034
New +$273K
LDOS icon
152
Leidos
LDOS
$17.3B
$273K 0.03%
3,419
ADP icon
153
Automatic Data Processing
ADP
$108B
$271K 0.03%
+1,640
New +$266K
TROW icon
154
T. Rowe Price
TROW
$24.3B
$263K 0.03%
2,395
+5
+0.2% +$526
PHM icon
155
Pultegroup
PHM
$25.3B
$261K 0.03%
8,250
-1,600
-16% -$49.9K
AMT icon
156
American Tower
AMT
$80.4B
$255K 0.03%
1,246
+156
+14% +$31.4K
JPM.PRE.CL
157
DELISTED
JPMORGAN CHASE & CO. Depositary Shares, each representing a 1/400th interest in a share of 6.30% Non
JPM.PRE.CL
$253K 0.03%
9,775
DOC icon
158
Healthpeak Properties
DOC
$14.8B
$252K 0.03%
7,865
+500
+7% +$15.5K
DD icon
159
DuPont de Nemours
DD
$19.2B
$249K 0.03%
2,639
-29,705
-92% -$3.55M
IDXX icon
160
Idexx Laboratories
IDXX
$46.2B
$248K 0.03%
900
ELME
161
Elme Communities
ELME
$144M
$241K 0.03%
9,000
-4,705
-34% -$130K
IBB icon
162
iShares Biotechnology ETF
IBB
$9.71B
$241K 0.03%
2,205
XLF icon
163
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$238K 0.03%
8,637
-5,122
-37% -$139K
AVY icon
164
Avery Dennison
AVY
$13.4B
$220K 0.03%
1,900
STZ icon
165
Constellation Brands
STZ
$23.2B
$210K 0.02%
+1,065
New +$208K
AXON
166
Axon Enterprise
AXON
$46.4B
$208K 0.02%
+3,245
New +$212K
COF icon
167
Capital One
COF
$134B
$206K 0.02%
+2,270
New +$203K
ASXC
168
DELISTED
Asensus Surgical, Inc.
ASXC
$110K 0.01%
6,221
SIRI icon
169
SiriusXM
SIRI
$10.1B
$57K 0.01%
1,027
PURE
170
DELISTED
PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
$20K ﹤0.01%
51,231
BWX icon
171
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.32B
-8,530
Closed -$238K
GILD icon
172
Gilead Sciences
GILD
$165B
-3,553
Closed -$231K
GLD icon
173
SPDR Gold Trust
GLD
$142B
-16,073
Closed -$1.96M
OXY icon
174
Occidental Petroleum
OXY
$55.9B
-3,748
Closed -$248K
VMC icon
175
Vulcan Materials
VMC
$36.9B
-98,373
Closed -$11.6M

Similar funds

Maryland Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Maryland Capital Management held 190 positions worth $843M, up 4.5% from $807M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Maryland Capital Management's Q2 2019 filing shows 11 new, 81 increased, 56 reduced and 7 closed positions. Its largest new stake was O'Reilly Automotive: 447,855 shares worth $11M. The largest sale was Vulcan Materials, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Maryland Capital Management's largest Q2 2019 buy was O'Reilly Automotive: 447,855 shares worth $11M.
  • Maryland Capital Management added most to Intuitive Surgical in Q2 2019, an estimated $11.9M increase.
  • Maryland Capital Management's biggest Q2 2019 reduction was PayPal, cutting an estimated $4.09M.
  • Maryland Capital Management fully exited Vulcan Materials in Q2 2019, selling an estimated $11.6M.
  • Maryland Capital Management's ten largest holdings make up 36% of its $843M portfolio in Q2 2019.
  • Maryland Capital Management opened 11 new positions and closed 7 in Q2 2019.
  • Maryland Capital Management's portfolio value rose 4.5% quarter-over-quarter to $843M.

Based on Maryland Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.